Authorization

Merieux Equity Partners Successfully Completes the Fundraising of the Merieux Participations 3

LYON, France, Jan. 8, 2020 /PRNewswire/ --A MA©rieux Equity Partners announces the closing of the fundraising for MA©rieux Participations 3, new investment fund dedicated to Growth Capital and Buy-Out within the Healthcare and Nutrition sectors, oversubscribed at a?¬ 377 million.
Merieux Equity Partners Successfully Completes the Fundraising of the Merieux Participations 3
Dedicated to supporting profitable and fast-growing companies in the healthcare and nutrition sectors, MA©rieux Participations 3 fund was launched with the support of Institut MA©rieux as a sponsor and an initial hard cap ofA a?¬ 350 million. In December 2019, the new vehicle closed at a?¬ 377 million, with commitments from leading European Family Holdings and Institutions.As part of its development, MA©rieux Equity Partners expanded its investment team in 2019 with the appointment of Marie-Justine Lecomte and Romain Chevrillon as Associates within the Growth Capital and Buy-Out team and now employs 16 staff members in Lyon, Paris and Boston, of which 8 resources dedicated to Growth Capital & Buy-Out.To date, MA©rieux Participations 3 has completed seven transactions in France and Europe in support of fast-growing industrial companies, including four majority deals. In 2019, MA©rieux Equity Partners invested in Addmedica a?? a French specialty pharmaceutical company engaged in rare diseases, Doc Generici a?? Italy's largest independent generic pharmaceutical company a?? and more recently Mabtech, a Swedish life science company specialized in immune monitoring.
See also:
Leave a comment
News
  • Latest
  • Read
  • Commented
Calendar Content
«    Сентябрь 2020    »
ПнВтСрЧтПтСбВс
 123456
78910111213
14151617181920
21222324252627
282930